Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Real-World Multicenter Study of PD-1 Blockade in HIV-Associated Hodgkin Lymphoma across the United States

Blood (2023) 142 (Supplement 1): 3071.

https://doi.org/10.1182/blood-2023-174589

Published: 2023

Journal Articles

Genetic subgroups inform on pathobiology in adult and pediatric Burkitt lymphoma

Nicole Thomas, Kostiantyn Dreval, Daniela S. Gerhard, Laura K. Hilton, Jeremy S. Abramson, Richard F. Ambinder, Stefan Barta, Nancy L. Bartlett, Jeffrey Bethony, Kishor Bhatia, Jay Bowen, Anthony C. Bryan, Ethel Cesarman, Corey Casper, Amy Chadburn, Manuela Cruz, Dirk P. Dittmer, Maureen A. Dyer, Pedro Farinha, Julie M. Gastier-Foster, Alina S. Gerrie, Bruno M. Grande, Timothy Greiner, Nicholas B. Griner, Thomas G. Gross, Nancy L. Harris, John D. Irvin, Elaine S. Jaffe, David Henry, Rebecca Huppi, Fabio E. Leal, Michael S. Lee, Jean Paul Martin, Marie-Reine Martin, Sam M. Mbulaiteye, Ronald Mitsuyasu, Vivian Morris, Charles G. Mullighan, Andrew J. Mungall, Karen Mungall, Innocent Mutyaba, Mostafa Nokta, Constance Namirembe, Ariela Noy, Martin D. Ogwang, Abraham Omoding, Jackson Orem, German Ott, Hilary Petrello, Stefania Pittaluga, James D. Phelan, Juan Carlos Ramos, Lee Ratner, Steven J. Reynolds, Paul G. Rubinstein, Gerhard Sissolak, Graham Slack, Shaghayegh Soudi, Steven H. Swerdlow, Alexandra Traverse-Glehen, Wyndham H. Wilson, Jasper Wong, Robert Yarchoan, Jean C. ZenKlusen, Marco A. Marra, Louis M. Staudt, David W. Scott, Ryan D. Morin

Blood (2023) 141 (8): 904–916.

https://doi.org/10.1182/blood.2022016534

Published: 2023

Includes: Supplemental data

Journal Articles

A Phase Ib Study of the Safety and Efficacy of Venetoclax When Combined with Escalating Doses of Omacetaxine in Patients with Relapsed/Refractory Acute Myeloid Leukemia Failing Treatment with Venetoclax-Containing Regimens (VEN-OM)

Ana Maria Avila, Saad Arain, Karen Sweiss, Pritesh Patel, Samin Houshyar, Gregory S Calip, Irum Khan, Paul G. Rubinstein, Chukwuemeka Uzoka, John G. Quigley

Blood (2022) 140 (Supplement 1): 11774–11775.

https://doi.org/10.1182/blood-2022-165565

Published: 2022

Journal Articles

Updated Analyses: Safety and Efficacy of Gemtuzumab Ozogamicin and Venetoclax in Patients with Relapsed or Refractory CD33+ Acute Myeloid Leukemia: A Phase Ib/II Study

Saad Arain, Ana Maria Avila, Sonia Christian, Pritesh Patel, Karen Sweiss, Brian Parkin, Santosh L. Saraf, Paul G. Rubinstein, Gregory S Calip, John G. Quigley

Blood (2022) 140 (Supplement 1): 11725–11726.

https://doi.org/10.1182/blood-2022-165615

Published: 2022

Journal Articles

KSHV/HHV8-mediated hematologic diseases

Ethel Cesarman, Amy Chadburn, Paul G. Rubinstein

Blood (2022) 139 (7): 1013–1025.

https://doi.org/10.1182/blood.2020005470

Published: 2022

Journal Articles

Impact of Myc in HIV-associated non-Hodgkin lymphomas treated with EPOCH and outcomes with vorinostat (AMC-075 trial)

Juan C. Ramos, Joseph A. Sparano, Amy Chadburn, Erin G. Reid, Richard F. Ambinder, Eric R. Siegel, Page C. Moore, Paul G. Rubinstein, Christine M. Durand, Ethel Cesarman, David Aboulafia, Robert Baiocchi, Lee Ratner, Lawrence Kaplan, Adam A. Capoferri, Jeannette Y. Lee, Ronald Mitsuyasu, Ariela Noy

Blood (2020) 136 (11): 1284–1297.

https://doi.org/10.1182/blood.2019003959

Published: 2020

Includes: Supplemental data

Journal Articles

Safety and Efficacy of Brentuximab Vedotin in Combination with AVD in Stage II-IV HIV-Associated Classical Hodgkin Lymphoma: Results of the Phase 2 Study, AMC 085

Blood (2019) 134 (Supplement_1): 130.

https://doi.org/10.1182/blood-2019-126787

Published: 2019

Journal Articles

A Randomized Trial of EPOCH-Based Chemotherapy with Vorinostat for Highly Aggressive HIV-Associated Lymphomas: Updated Results Evaluating Impact of Diagnosis-to-Treatment Interval (DTI) and Pre-Protocol Systemic Therapy on Outcomes

Juan Carlos Ramos, MD BS, Joseph Sparano, MD, Page C. Moore, PhD, Eric Siegel, Jeannette Y Lee, PhD, Erin G. Reid, MD MS, Richard F. Ambinder, MD, Amy Chadburn, MD, Paul G. Rubinstein, MD, Christine Durand, Ethel Cesarman, MD PhD, Lee Ratner, MD PhD, Robert A Baiocchi, MD PhD, David M. Aboulafia, MD, Lawrence D Kaplan, MD, Adam Capoferri, Ronald T. Mitsuyasu, MD, Ariela Noy, MD

Blood (2019) 134 (Supplement_1): 1588.

https://doi.org/10.1182/blood-2019-129687

Published: 2019

Journal Articles

Characteristics, Social Factors, and Trends in HIV and AIDS-Related Lymphoma: A 23-Year Analysis Since the Implementation of c ART, a County Hospital AIDS Malignancy Project (CHAMP) Study

Camille E. Demarco, MPH, Pei Lu, MD, David F. Peace, Sunny Singh, MD, Dennis F. Angelov, Kelly A. Benante, MPH, Ahmed T. Ahmed, MD, Paul G. Rubinstein, MD

Blood (2018) 132 (Supplement 1): 2304.

https://doi.org/10.1182/blood-2018-99-117391

Published: 2018

Journal Articles

The Landscape of microRNA Expression in HIV and Non-HIV Associated Classical Hodgkin Lymphoma through Next Generation Sequencing

Paul G. Rubinstein, MD, Andrea B. Moffitt, Kelly A. Petrowski, MPH, Marina Messinger, MD, Nicholas Davis, Cassandra Love, Sandeep Dave, MD, Amy Chadburn, MD

Blood (2015) 126 (23): 2639.

https://doi.org/10.1182/blood.V126.23.2639.2639

Published: 2015

Journal Articles

AIDS-Related Vs. Non-AIDS-Related Diffuse Large B-Cell Lymphoma. Analysis of the County Hospital AIDS Malignancy Project (CHAMP)

Kelly A. Petrowski, MPH, Harsha Poola, MD, Katherine Lee Chuy, MD, Shweta Gupta, MD, Paul G. Rubinstein, MD

Blood (2015) 126 (23): 2684.

https://doi.org/10.1182/blood.V126.23.2684.2684

Published: 2015

Journal Articles

AMC-085: A Pilot Trial of AVD and Brentuximab Vedotin in the Upfront Treatment of Stage II-IV HIV-Associated Hodgkin Lymphoma. A Trial of the AIDS Malignancy Consortium

Paul G. Rubinstein, MD, Page Moore, PhD, David H. Henry, MD, Lee Ratner, MD PhD, Elad Sharon, MD MPH, Ariela Noy, MD

Blood (2015) 126 (23): 1526.

https://doi.org/10.1182/blood.V126.23.1526.1526

Published: 2015

Journal Articles

Flow sorting and exome sequencing reveal the oncogenome of primary Hodgkin and Reed-Sternberg cells

Jonathan Reichel, Amy Chadburn, Paul G. Rubinstein, Lisa Giulino-Roth, Wayne Tam, Yifang Liu, Rafael Gaiolla, Kenneth Eng, Joshua Brody, Giorgio Inghirami, Carmelo Carlo-Stella, Armando Santoro, Daoud Rahal, Jennifer Totonchy, Olivier Elemento, Ethel Cesarman, Mikhail Roshal

Blood (2015) 125 (7): 1061–1072.

https://doi.org/10.1182/blood-2014-11-610436

Published: 2015

Includes: Supplemental data

Journal Articles

Initial Experience with Thrombopoetin Receptor Agonists (TRA) in 5 Patients with Refractory HIV-Associated Immune Thrombocytopenic Purpura (ITP)

Mark Kowalczyk, Paul G. Rubinstein, MD, David M Aboulafia, MD

Blood (2014) 124 (21): 5014.

https://doi.org/10.1182/blood.V124.21.5014.5014

Published: 2014

Journal Articles

Microenvironment Assessment, Disease Characteristics and Prognosis In HIV-Associated (HIV-cHL) and HIV-Negative Classical Hodgkin Lymphoma: The Influence Of Epstein Barr Virus (EBV)

Paul G. Rubinstein, MD, Shylendra Sreenivasappa, MD, Marina Messinger, MD, Adam M. Petrich, MD, Jonathan Moreira, MD, Locke J. Bryan, MD, Victoria Angelova, MD, Shweta Gupta, MD, Ariela Noy, MD, Ingrid Sumpter, BS, Ethel Cesarman, MD, PhD, Amy Chadburn, M.D.

Blood (2013) 122 (21): 2996.

https://doi.org/10.1182/blood.V122.21.2996.2996

Published: 2013

Journal Articles

HIV Vs. Non-HIV- Associated Classic Hodgkin Lymphoma: Similar Outcomes But a Clear Racial Disparity In The Inner City

Marina Messinger, MD, Kamila lzabela Cisak, MD, Surabhi Pathak, MD, Patricia Sumoza, Shweta Gupta, MD, Paul G. Rubinstein, MD

Blood (2013) 122 (21): 1755.

https://doi.org/10.1182/blood.V122.21.1755.1755

Published: 2013

Journal Articles

A Retrospective Analysis of All Hematological Malignancies in Patients Infected with HIV, a Subset Analysis of the CHAMP Study (Cook County Hospital (CCH) AIDS Malignancy Project),

Shweta Gupta, MD, Shivi Jain, MD, Sonia Sandhu, MD, Shylendra Sreenivasappa, MD, Shinoj Pattali, MD, Tareq Braik, MD, Margaret Telfer, MD, Audrey French, MD, Paul G. Rubinstein, MD

Blood (2011) 118 (21): 3693.

https://doi.org/10.1182/blood.V118.21.3693.3693

Published: 2011

Journal Articles

Clinical Significance of Positive Red Blood Cell Antibody Screen with Inconclusive Antibody Identification

Shweta Gupta, MD, Prantesh Jain, MD, Harsha v Poola, MD, Sumedha Dhar, MD, Manila Gaddh, MD, Paul G. Rubinstein, MD, Tareq Braik, MD, Rosalind Catchatourian, MD, Margaret Clare Telfer, MD, FACP, Ram Kakaiya, MD

Blood (2011) 118 (21): 4340.

https://doi.org/10.1182/blood.V118.21.4340.4340

Published: 2011

Journal Articles

Efficacy of Novel Agents in Multiple Myeloma in Comparison to Autologous Stem Cell Transplant: A Retrospective Study in a Single Inner City Institution

Tareq Braik, MD, Dayra Avila, MD, Shivi Jain, MD, Manila Gaddh, MD, Barabara Yim, PharmD, Peter Ruestow, MPH, Shylendra B Sreenivasappa, MD, Shweta Gupta, MD, Sylvia Velinova, MD, Paul G. Rubinstein, MD, Margaret Telfer, MD, Mousami Shah, MD, Thomas Lad, Rosalind Catchatourian, MD

Blood (2011) 118 (21): 5118.

https://doi.org/10.1182/blood.V118.21.5118.5118

Published: 2011

Journal Articles

Single 4.5mg Dose of Rasburicase for Tumor Lysis Syndrome In Adults

Barbara Yim, PharmD, BCOP, Anne Navaleza, PharmD, Augustin Haidau, MD, Shylendra Sreenivasappa, MD, MPH, Mohammed A. Kassem, MD, Bety C. Ciobanu, MD, Tareq Braik, MD, Manila Gaddh, MD, Paul G. Rubinstein, MD, Moushmi Shah, MD, Margaret Telfer, MD, Rose Catchatourian, MD

Blood (2010) 116 (21): 1779.

https://doi.org/10.1182/blood.V116.21.1779.1779

Published: 2010

NARROW

Real-World Multicenter Study of PD-1 Blockade in HIV-Associated Hodgkin Lymphoma across the United States

Genetic subgroups inform on pathobiology in adult and pediatric Burkitt lymphoma

A Phase Ib Study of the Safety and Efficacy of Venetoclax When Combined with Escalating Doses of Omacetaxine in Patients with Relapsed/Refractory Acute Myeloid Leukemia Failing Treatment with Venetoclax-Containing Regimens (VEN-OM)

Updated Analyses: Safety and Efficacy of Gemtuzumab Ozogamicin and Venetoclax in Patients with Relapsed or Refractory CD33+ Acute Myeloid Leukemia: A Phase Ib/II Study

KSHV/HHV8-mediated hematologic diseases

Impact of Myc in HIV-associated non-Hodgkin lymphomas treated with EPOCH and outcomes with vorinostat (AMC-075 trial)

Safety and Efficacy of Brentuximab Vedotin in Combination with AVD in Stage II-IV HIV-Associated Classical Hodgkin Lymphoma: Results of the Phase 2 Study, AMC 085

A Randomized Trial of EPOCH-Based Chemotherapy with Vorinostat for Highly Aggressive HIV-Associated Lymphomas: Updated Results Evaluating Impact of Diagnosis-to-Treatment Interval (DTI) and Pre-Protocol Systemic Therapy on Outcomes

Characteristics, Social Factors, and Trends in HIV and AIDS-Related Lymphoma: A 23-Year Analysis Since the Implementation of c ART, a County Hospital AIDS Malignancy Project (CHAMP) Study

The Landscape of microRNA Expression in HIV and Non-HIV Associated Classical Hodgkin Lymphoma through Next Generation Sequencing

AIDS-Related Vs. Non-AIDS-Related Diffuse Large B-Cell Lymphoma. Analysis of the County Hospital AIDS Malignancy Project (CHAMP)

AMC-085: A Pilot Trial of AVD and Brentuximab Vedotin in the Upfront Treatment of Stage II-IV HIV-Associated Hodgkin Lymphoma. A Trial of the AIDS Malignancy Consortium

Flow sorting and exome sequencing reveal the oncogenome of primary Hodgkin and Reed-Sternberg cells

Initial Experience with Thrombopoetin Receptor Agonists (TRA) in 5 Patients with Refractory HIV-Associated Immune Thrombocytopenic Purpura (ITP)

Microenvironment Assessment, Disease Characteristics and Prognosis In HIV-Associated (HIV-cHL) and HIV-Negative Classical Hodgkin Lymphoma: The Influence Of Epstein Barr Virus (EBV)

HIV Vs. Non-HIV- Associated Classic Hodgkin Lymphoma: Similar Outcomes But a Clear Racial Disparity In The Inner City

A Retrospective Analysis of All Hematological Malignancies in Patients Infected with HIV, a Subset Analysis of the CHAMP Study (Cook County Hospital (CCH) AIDS Malignancy Project),

Clinical Significance of Positive Red Blood Cell Antibody Screen with Inconclusive Antibody Identification

Efficacy of Novel Agents in Multiple Myeloma in Comparison to Autologous Stem Cell Transplant: A Retrospective Study in a Single Inner City Institution

Single 4.5mg Dose of Rasburicase for Tumor Lysis Syndrome In Adults

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only